Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 2
2004 3
2006 1
2007 1
2010 1
2012 1
2013 1
2014 1
2015 1
2016 1
2017 6
2018 5
2019 5
2020 4
2021 5
2022 7
2023 4
2024 4
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.
Koster NG, van den Reek JMPA, de Jong EMGJ, van Beugen S, van Laarhoven AIM, Haeck I, de Bruin-Weller M, Schuttelaar ML, Horvath B, Gostyński A, Knulst A, Vermeer MH, Nguyen L, Gerbens L, Spuls P, Middelkamp-Hup MA, Exadaktylos V, Niemeyer-van der Kolk T, Schrader AR, Sluijmers AM, Versteeg J, Arents BWM, van Ee I, van der Zon JLAG, de Leeuw M, de Leeuw T, van den Broek P, Berkhof C, Vellinga D, Weidinger S, Dubrac S, Li Y, van Steensel M, Marchetti-Deschmann M, Maurer M, van der Zee H, Damman J, Hijnen DJ, Wijk F, Seyger MMB, Röckmann H, Balak DMW, van Doorn MBA, Rissmann R; Next Generation ImmunoDermatology (NGID) consortium. Koster NG, et al. Among authors: middelkamp hup ma. J Eur Acad Dermatol Venereol. 2026 Feb 6. doi: 10.1111/jdv.70311. Online ahead of print. J Eur Acad Dermatol Venereol. 2026. PMID: 41645921
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce.
Musters AH, Gerbens LAA, van der Gang L, Middelkamp-Hup MA, Ouwerkerk W, Hijnen DJ, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, Svedbom A, Johansson EK, Bradley M, von Kobyletzki LB, Vittrup I, Ruge IF, Thyssen JP, Vestergaard C, Carrascosa JM, de Vega M, García-Doval I, Chiricozzi A, Stingeni L, Calzavara-Pinton P, Ardern-Jones MR, Reynolds NJ, Flohr C, Spuls PI; A‐STAR, AtopyReg, BIOBADATOP, SCRATCH, SwedAD, TREATgermany and TREAT NL/BE registry teams. Musters AH, et al. Among authors: middelkamp hup ma. J Eur Acad Dermatol Venereol. 2025 Dec;39(12):2096-2112. doi: 10.1111/jdv.20876. Epub 2025 Aug 20. J Eur Acad Dermatol Venereol. 2025. PMID: 40832875 Free PMC article.
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
Knöps E, Spuls P, Duijnhoven R, Dijkgraaf M, van Barreveld M, Arents B, van Enst A, Garritsen F, Merkus M, Middelkamp-Hup MA, Musters A, Bosma A, Hyseni A, Dijkstra J, Hijnen DJ, Gerbens L. Knöps E, et al. Among authors: middelkamp hup ma. Trials. 2025 Feb 17;26(1):55. doi: 10.1186/s13063-025-08774-1. Trials. 2025. PMID: 39962617 Free PMC article. No abstract available.
Drug Survival of Dupilumab, Methotrexate, and Cyclosporine A in Children With Atopic Dermatitis.
van der Rijst LP, Kamphuis E, Schuttelaar MLA, Hurmuz R, Seyger MMB, Caron AGM, Zuithoff NPA, Nguyen NT, Kamsteeg M, de Bruin-Weller MS, Pasmans SGMA, Middelkamp-Hup MA, de Graaf M. van der Rijst LP, et al. Among authors: middelkamp hup ma. JAMA Dermatol. 2025 Jan 1;161(1):12-21. doi: 10.1001/jamadermatol.2024.3717. JAMA Dermatol. 2025. PMID: 39412782 Free PMC article.
International consensus on methotrexate dosing for patients with atopic dermatitis: An eDelphi study.
Caron AGM, van Huizen AM, Musters AAH, Gerbens LAA, Middelkamp Hup MA, Flohr C, Irvine AD, Vestergaard C, Peris K, Brandling-Bennett HA, Drucker AM, Spuls PI; MTX Consensus for AD Survey Study Group. Caron AGM, et al. Among authors: middelkamp hup ma. J Eur Acad Dermatol Venereol. 2025 Feb;39(2):331-339. doi: 10.1111/jdv.20271. Epub 2024 Aug 1. J Eur Acad Dermatol Venereol. 2025. PMID: 39087636 Free PMC article.
The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
Knöps E, Spuls P, Duijnhoven R, Dijkgraaf M, van Barreveld M, Arents B, van Enst A, Garritsen F, Merkus M, Middelkamp-Hup MA, Musters A, Bosma A, Hyseni A, Dijkstra J, Hijnen DJ, Gerbens L. Knöps E, et al. Among authors: middelkamp hup ma. Trials. 2024 Jul 16;25(1):482. doi: 10.1186/s13063-024-08334-z. Trials. 2024. PMID: 39014498 Free PMC article.
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.
Ramessur R, Dand N, Langan SM, Saklatvala J, Fritzsche MC, Holland S, Arents BWM, McAteer H, Proctor A, McMahon D, Greenwood M, Buyx AM, Messer T, Weiler N, Hicks A, Hecht P, Weidinger S, Ndlovu MN, Chengliang D, Hübenthal M, Egeberg A, Paternoster L, Skov L, De Jong EMGJ, Middelkamp-Hup MA, Mahil SK, Barker JN, Flohr C, Brown SJ, Smith CH. Ramessur R, et al. Among authors: middelkamp hup ma. Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
Musters AH, van Lookeren FL, van der Gang LF, Middelkamp-Hup MA, Bosma AL, Jessurun NT, Lapeere H, Nguyen AL, Ouwerkerk W, de Schepper S, Gerbens LAA, Spuls PI. Musters AH, et al. Among authors: middelkamp hup ma. J Eur Acad Dermatol Venereol. 2024 Mar;38(3):530-542. doi: 10.1111/jdv.19643. Epub 2023 Nov 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38031478
Expanding the molecular and clinical spectrum of autosomal recessive congenital ichthyosis caused by pathogenic variants in NIPAL4 and PNPLA1 and evaluation of novel therapeutic interventions.
Rossel SVJ, Clabbers JMK, Steijlen PM, van den Akker PC, Spuls PI, Middelkamp Hup MA, van Maarle MC, Vreeburg M, Bolling MC, van Geel M, Gostyński A. Rossel SVJ, et al. Among authors: middelkamp hup ma. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):e1405-e1409. doi: 10.1111/jdv.19340. Epub 2023 Jul 24. J Eur Acad Dermatol Venereol. 2023. PMID: 37458571 No abstract available.
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
Bosma AL, Ouwerkerk W, Heidema MJ, Prieto-Merino D, Ardern-Jones MR, Beattie P, Brown SJ, Ingram JR, Irvine AD, Ogg G, Patel P, Reynolds NJ, Hearn RMR, Wan M, Warren RB, Woolf RT, Hyseni AM, Gerbens LAA, Spuls PI, Flohr C, Middelkamp-Hup MA; TREAT NL registry and UK-Irish A-STAR Study Groups. Bosma AL, et al. Among authors: middelkamp hup ma. JAAD Int. 2022 Oct 10;10:14-24. doi: 10.1016/j.jdin.2022.09.006. eCollection 2023 Mar. JAAD Int. 2022. PMID: 36387062 Free PMC article.
50 results